Prediction of early-stage melanoma recurrence using clinical and histopathologic features

Prognostic analysis for early-stage (stage I/II) melanomas is of paramount importance for customized surveillance and treatment plans. Since immune checkpoint inhibitors have recently been approved for stage IIB and IIC melanomas, prognostic tools to identify patients at high risk of recurrence have...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Guihong, Nguyen, Nga, Liu, Feng, DeSimone, Mia S., Leung, Bonnie W., Rajeh, Ahmad, Collier, Michael R., Choi, Min Seok, Amadife, Munachimso, Tang, Kimberly, Zhang, Shijia, Phillipps, Jordan S., Jairath, Ruple, Alexander, Nora A., Hua, Yining, Jiao, Meng, Chen, Wenxin, Ho, Diane, Duey, Stacey, Németh, István Balázs, Marko-Varga, Gyorgy, Valdés, Jeovanis Gil, Liu, David, Boland, Genevieve M., Gusev, Alexander, Sorger, Peter K., Yu, Kun-Hsing, Semenov, Yevgeniy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622809/
https://www.ncbi.nlm.nih.gov/pubmed/36316482
http://dx.doi.org/10.1038/s41698-022-00321-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622809/
https://www.ncbi.nlm.nih.gov/pubmed/36316482
http://dx.doi.org/10.1038/s41698-022-00321-4

Ejemplares similares